Sponsor intelligence · OTHER
Clinical trials sponsored by
Shanghai Junshi Bioscience Co., Ltd..
Real, source-linked trial activity for Shanghai Junshi Bioscience Co., Ltd.: 1 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 19, 2026. Source-linked, daily-refreshed.
PHASE3 1
Newest Shanghai Junshi Bioscience Co., Ltd. trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 4d ago | JS207 Plus JS007 Versus Toripalimab Plus Bevacizumab as First-Line Tre | Ph 3 | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Shanghai Junshi Bioscience Co., Ltd. (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.